Tag: Rama Padmanabhan
GSK to acquire Chimagen asset in deal worth up to USD750m
Pharmaceutical giant GSK enters into an asset purchase agreement with Chimagen Biosciences valued at up to USD750 million
Six firms assist on AstraZeneca’s USD1.2bn Gracell purchase
Six firms act for parties involved with Anglo-Swedish pharmaceutical giant AstraZeneca’s acquisition of Chinese peer Gracell Biotechnologies for USD1.2 billion
